Our TWAS analyses provide evidence that expression of MS4A4A and MS4A6A in CD14+ monocytes is relevant to Alzheimer’s disease risk, although conditional analyses are unable to conclusively localise the signal to either of these genes. This evidence concerns the gene MS4A4A and early-onset autosomal dominant Alzheimer disease.